The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor-Reference-Cited by-同舟云学术

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor

Published:2017-02-20 Issue:1 Volume:15 Page:
ISSN:1477-9560
Container-title:Thrombosis Journal
language:en
Short-container-title:Thrombosis J

Author:

Schultz Nina Haagenrud,Tran Hoa Thi Tuyet,Bjørnsen Stine,Henriksson Carola Elisabeth,Sandset Per Morten,Holme Pål Andre

Funder

Bayer HealthCare

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1186/s12959-017-0129-1.pdf

Reference34 articles.

1. van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124:1968–75.

2. Yeh CH, Hogg K, Weitz JI. Overview of the new oral anticoagulants: opportunities and challenges. Arterioscler Thromb Vasc Biol. 2015;35:1056–65.

3. Coleman CI, Antz M, Bowrin K, Evers T, Simard EP, Bonnemeier H, et al. Real-world evidence on stroke prevention in patients with atrial fibrillation in the United States: the REVISIT-US study. Curr Med Res Opin. 2016;32:2047–53.

4. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–91.

5. Eerenberg ES, Middeldorp S, Levi M, Lensing AW, Büller HR. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists. J Thromb Haemost. 2015;13:1590–6.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding;European Journal of Anaesthesiology;2024-04-04

2. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage;Hospital Pharmacy;2024-02-16

3. Real-world national trends and influencing factors preference of non-vitamin K antagonist oral anticoagulants in China;Frontiers in Medicine;2023-11-21

4. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03

5. A Historical Perspective on the Reversal of Anticoagulants;Seminars in Thrombosis and Hemostasis;2022-09-02